Home›Stock Screener›Nidan Labs & Healthcare

Nidan Labs & Healthcare Share Price Today | Stock Price & Nidan Labs & Healthcare Share Screener

NIDAN Healthcare Service Provider

Track the current Nidan Labs & Healthcare share price and stock price live with TickJournal's free stock screener. Check NIDAN annual price range for the annual price range and momentum. Use the Nidan Labs & Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Nidan Labs & Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹24 and net income of ₹3, with EBITDA of ₹9, an operating margin of 19.0% and a profit margin of 12.5%.

Nidan Labs & Healthcare Market Cap ₹17.44 Cr.
NIDAN P/E Ratio (TTM) 11.94
Nidan Labs & Healthcare P/B Ratio 0.26
EPS (TTM) ₹1.08
Dividend Yield -
Debt to Equity 0.18
NIDAN 52 Week High -
Nidan Labs & Healthcare 52 Week Low -
Operating Margin 19.00%
Profit Margin 12.50%
NIDAN Revenue (TTM) ₹24.00
EBITDA ₹9.00
Net Income ₹3.00
Total Assets ₹84.00
Total Equity ₹70.00

Nidan Labs & Healthcare Share Price Chart

Track the current stock price of Nidan Labs & Healthcare with an interactive chart. Analyse NIDAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Nidan Labs & Healthcare stock quote in one place.

Nidan Labs & Healthcare Company Profile - Fundamental Screener

Screen Nidan Labs & Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NIDAN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE0J6L01013.

Company Details

Classification

Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E

Identifiers and Leadership

ISIN INE0J6L01013

Nidan Labs & Healthcare Balance Sheet Screener

Screen NIDAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹84, up from ₹83 in 2025.

Latest statistics put total assets at ₹84 and shareholder funds at ₹70, with a leverage ratio of 0.18.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 84 83 83 84 89 54 45 43
Current Assets 15 11 30 21 25 23 24 19
Fixed Assets 15 16 18 21 21 20 20 23

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 4 5 5 5 10 14 34 32
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 70 68 66 69 66 13 11 10
Share Capital 14 14 14 14 14 10 10 10
Reserves & Surplus 56 54 52 56 52 3 1 0

Nidan Labs & Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Nidan Labs & Healthcare income statement and profit fundamentals. Analyze NIDAN quarterly results. Nidan Labs & Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹24 and net profit was ₹3, equal to earnings per unit of ₹2.90, at an operating margin of 19%.

In that period expenses were ₹15, interest cost ₹3 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹27 and net profit of ₹2.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Revenue and Expenses

Revenue 24 27 27 27 28 30 21 22 21
Expenses 15 21 20 18 18 20 12 15 13

Operating Costs and Margins

EBITDA 9 7 7 9 10 10 10 8 8
Operating Profit % 19.00% 19.00% 21.00% 27.00% 28.00% 32.00% 44.00% 34.00% 38.00%
Depreciation 3 2 2 3 3 3 3 3 3
Interest 3 2 2 2 2 3 4 4 5

Profit and Earnings

Profit Before Tax 4 2 3 -2 5 5 3 1 0
Tax 1 1 1 1 1 2 1 0 0
Net Profit 3 2 2 -3 4 3 2 1 0
EPS 2.90 1.08 1.42 -2.33 2.55 2.32 2.33 0.72 0.23

Nidan Labs & Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen NIDAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹2.

Over the same period, investing activities provided ₹0 and financing activities used ₹2.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 2 2 6 11 8 4 5 9
Investing Activities 0 0 -11 0 -36 -3 0 1

Financing and Net Cash

Financing Activities -2 -3 -1 -10 29 -1 -2 -6
Net Cash Flow 0 -1 -6 0 1 0 3 4

Nidan Labs & Healthcare Shareholding Pattern Screener

See Nidan Labs & Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Nidan Labs & Healthcare promoter holding and ownership changes for NIDAN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 57.04%, foreign institutions 0.00%, domestic institutions 0.00% and the public 40.05%, spread across 2,362 shareholders.

The shareholder count was 2,362 in 2026-Mar, compared with 2,359 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Sept 2025-Dec 2024-Mar 2024-Sept 2023-Mar

Promoter Holding

Promoter Holding 57.04% 57.04% 57.04% 57.04% 57.04% 57.04% 57.04% 71.22%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 40.05% 39.94% 39.78% 40.01% 40.05% 39.33% 39.60% 26.62%
Other Holding 2.92% 3.02% 3.18% 2.95% 2.92% 3.64% 3.36% 2.16%
Shareholder Count 2,362 2,359 2,581 2,489 2,437 2,864 2,790 2,440

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Nidan Labs & Healthcare. Nidan Labs & Healthcare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Nidan Labs & Healthcare.

Nidan Labs & Healthcare Stock Index Membership - Nifty & Sensex

See which indices include Nidan Labs & Healthcare stock. Check NIDAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Nidan Labs & Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Nidan Labs & Healthcare Market Events Screener - Corporate Actions

Get Nidan Labs & Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Nidan Labs & Healthcare stock events that may affect NIDAN share price, along with derivatives, futures and options activity and sector gainers.

5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 25, 2026, with a record date of May 25, 2026.

It is followed by Quarterly Result Announcement dated November 10, 2025 and Quarterly Result Announcement dated May 28, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-05-25 2026-05-25 Quarterly Result Announcement NA 2.50%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 9.14%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 14.81%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -1.64%
2024-09-27 2024-09-27 Annual General Meeting NA -1.81%

Nidan Labs & Healthcare Competitors Screener - Peer Stocks Comparison

Screen NIDAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 33,352 60.10 2,864 12.11% 510 64.65
Vijaya Diagnostic Centre 14,808 81.17 835 19.34% 173 42.34
Metropolis Healthcare 11,234 57.53 1,671 24.15% 191 33.31
Thyrocare Technologies 8,502 49.47 846 20.48% 163 36.26
Nephrocare Health Services 6,634 78.39 1,023 32.93% 77 34.74
Suraksha Diagnostic 1,851 52.79 314 22.55% 31 65.93
Krsnaa Diagnostics 1,816 18.47 816 9.90% 101 53.67
3B BlackBio DX 1,468 24.79 142 27.17% 61 72.60
One Global Service Provider 1,032 14.13 499 237.48% 70 43.80
Health X Platform 907 -34.91 1,378 17.65% -1 37.93

Nidan Labs & Healthcare Company Announcements - News & Reports Screener

Screen NIDAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 11.94 and the P/B ratio is 0.26, with earnings per unit of ₹1.08. Market capitalisation stands at ₹17.44 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 9 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.